Company Search:
Advanced Search
Sponsored Links
Newron Pharmaceuticals Spa Company Snapshot
Newron Pharmaceuticals Spa operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Newron Pharmaceuticals Spa with three other miscellaneous service companies in Europe: MaxCyte Inc of the United Kingdom (2017 sales of £10.74 million [US$13.41 million] of which 100% was Medical Service), Oncodesign Sa of France (14.31 million Euro [US$16.18 million] ), and Avantium NV which is based in the Netherlands (12.65 million Euro [US$14.31 million] of which 99% was Catalysis).

Sales Analysis. Sales increased substantially in 2017: During the year ended December of 2017, sales at Newron Pharmaceuticals Spa were 13.29 million Euro (US$15.03 million). This is an increase of 180.5% versus 2016, when the company's sales were 4.74 million Euro. This was the third consecutive year of growth at Newron Pharmaceuticals Spa.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Newron Pharmaceuticals Spa
  Stock Performance Chart for Newron Pharmaceuticals Spa
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 6.09
(Figures in Euro)
1 Week -11.3%   13 Weeks -15.7%  
4 Weeks -32.7%   52 Weeks -34.4%  
Newron Pharmaceuticals Spa Key Data:
  Ticker: NWRN Country: Italy
  Exchanges: ZHR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 13,285,000
(Year Ending Jan 2018).
Employees: 1
  Currency: Euro Market Cap: 108,734,516
  Fiscal Yr Ends: December Shares Outstanding: 17,844,345
  Share Type: Azioni Ordinaire Closely Held Shares: 3,135,635
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.